Literature DB >> 10220438

Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.

C Klein1, M F Brin, P Kramer, M Sena-Esteves, D de Leon, D Doheny, S Bressman, S Fahn, X O Breakefield, L J Ozelius.   

Abstract

Hereditary autosomal dominant myoclonus dystonia (MD) is a movement disorder characterized by involuntary lightning jerks and dystonic movements and postures alleviated by alcohol. Although various large families with MD have been described, no positive linkage has been found to a chromosomal location. We report a family with eight members with MD. Linkage analysis identified a 23-centimorgan region on chromosome 11q23 that cosegregates with the disease state (maximum multipoint logarithm of odds score = 2.96 at D11S897). This region contains an excellent candidate gene for involvement in the etiology of MD, the D2 dopamine receptor (DRD2) gene. Neurotransmission mediated by DRD2 is known to have a key role in the control of movement and also has been implicated in reward and reinforcement mechanisms and psychiatric disorders. Sequencing of the coding region of DRD2 indicated that all affected and obligate carriers were heterozygous for a Val154Ile change in exon 3 of the protein, which is highly conserved across species. This change was found neither in other unaffected members of the pedigree nor in 250 control chromosomes. Our finding provides evidence for the involvement of DRD2 in a disorder of the central nervous system and should lead to further insight into the function of the dopaminergic system in dystonia and other movement and mood disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220438      PMCID: PMC21836          DOI: 10.1073/pnas.96.9.5173

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Cloning of the cDNA and gene for a human D2 dopamine receptor.

Authors:  D K Grandy; M A Marchionni; H Makam; R E Stofko; M Alfano; L Frothingham; J B Fischer; K J Burke-Howie; J R Bunzow; A C Server
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.

Authors:  D K Grandy; M Litt; L Allen; J R Bunzow; M Marchionni; H Makam; L Reed; R E Magenis; O Civelli
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

Review 3.  Clinical and molecular genetics of primary dystonias.

Authors:  U Müller; D Steinberger; A H Németh
Journal:  Neurogenetics       Date:  1998-03       Impact factor: 2.660

4.  Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation.

Authors:  M Kyllerman; L Forsgren; G Sanner; G Holmgren; J Wahlström; U Drugge
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

5.  Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene.

Authors:  X Y Hauge; D K Grandy; J H Eubanks; G A Evans; O Civelli; M Litt
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

6.  Hereditary essential myoclonus in a large Norwegian family.

Authors:  S Fahn; O Sjaastad
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

7.  Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23.

Authors:  J H Eubanks; M Djabali; L Selleri; D K Grandy; O Civelli; D L McElligott; G A Evans
Journal:  Genomics       Date:  1992-12       Impact factor: 5.736

8.  Myoclonic dystonia.

Authors:  J A Obeso; J C Rothwell; A E Lang; C D Marsden
Journal:  Neurology       Date:  1983-07       Impact factor: 9.910

9.  Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

Authors:  R A Gatti; I Berkel; E Boder; G Braedt; P Charmley; P Concannon; F Ersoy; T Foroud; N G Jaspers; K Lange
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

10.  Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor.

Authors:  G Sarkar; S Kapelner; D K Grandy; M Marchionni; O Civelli; J Sobell; L Heston; S S Sommer
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

View more
  19 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  A major locus for myoclonus-dystonia maps to chromosome 7q in eight families.

Authors:  C Klein; K Schilling; R J Saunders-Pullman; J Garrels; X O Breakefield; M F Brin; D deLeon; D Doheny; S Fahn; J S Fink; L Forsgren; J Friedman; S Frucht; J Harris; G Holmgren; B Kis; R Kurlan; M Kyllerman; A E Lang; J Leung; D Raymond; J D Robishaw; G Sanner; E Schwinger; R E Tabamo; M Tagliati
Journal:  Am J Hum Genet       Date:  2000-10-05       Impact factor: 11.025

Review 3.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

4.  Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.

Authors:  Gonzalo E Torres; Ava L Sweeney; Jean-Martin Beaulieu; Pullani Shashidharan; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

Review 5.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism.

Authors:  Marlene B Lauritsen; Mette Nyegaard; Catalina Betancur; Catherine Colineaux; Trine L Josiassen; Torben A Kruse; Marion Leboyer; Henrik Ewald
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-08-15       Impact factor: 3.568

Review 7.  Genetic Aspects of Myoclonus-Dystonia Syndrome (MDS).

Authors:  Laila Rachad; Nadia El Kadmiri; Ilham Slassi; Hicham El Otmani; Sellama Nadifi
Journal:  Mol Neurobiol       Date:  2016-01-20       Impact factor: 5.590

Review 8.  Commentary: Dopaminergic dysfunction in DYT1 dystonia.

Authors:  Thomas Wichmann
Journal:  Exp Neurol       Date:  2008-04-26       Impact factor: 5.330

9.  Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

Authors:  Natalie M Frederick; Parth V Shah; Alessandro Didonna; Monica R Langley; Anumantha G Kanthasamy; Puneet Opal
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

10.  Potential Role of Brain-Derived Neurotrophic Factor and Dopamine Receptor D2 Gene Variants as Modifiers for the Susceptibility and Clinical Course of Wilson's Disease.

Authors:  Shubhrajit Roy; Prosenjit Pal; Sampurna Ghosh; Sreyashi Bhattacharya; Shyamal Kumar Das; Prasanta Kumar Gangopadhyay; Ashish Bavdekar; Kunal Ray; Mainak Sengupta; Jharna Ray
Journal:  Neuromolecular Med       Date:  2018-07-10       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.